Candidate Single-Nucleotide Polymorphisms From a Genomewide Association Study of Alzheimer Disease

  • Hosford D
  • Barnes M
  • Briley J
  • et al.
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Objective: To identify single-nucleotide polymor- phisms (SNPs) associated with risk and age at onset of Alzheimer disease(AD)in agenomewideassociation study of 469 438 SNPs. Design: Case-control study with replication. Setting:Memoryreferral clinics in Canada and the United Kingdom. Participants: The hypothesis-generating data set con- sisted of 753 individuals with AD by National Institute of Neurological and Communicative Diseases and Stroke/ Alzheimer’s Disease and Related Disorders Association criteria recruited from 9memory referral clinics in Canada and 736 ethnically matched control subjects; control sub- jects were recruited from nonbiological relatives, friends, or spouses of the patients and did not exhibit cognitive impairment by history or cognitive testing. The fol- low-up data set consisted of 418 AD cases and 249 non- demented control cases from the United Kingdom Medi- cal Research Council Genetic Resource for Late-Onset AD recruited from clinics at Cardiff University, Cardiff, Wales, and King’s College London, London, England. Main Outcome Measures: Odds ratios and 95% con- fidence intervals for association of SNPs with AD by lo- gistic regression adjusted for age, sex, education, study site, and French Canadian ancestry (for the Canadian data set). Hazard ratios and95%confidence intervals fromCox proportionalhazards regression for age at onset with simi- lar covariate adjustments. Results: Unadjusted,SNPRS4420638 withinAPOC1was strongly associated with AD due entirely to linkage dis- equilibrium with APOE. In the multivariable adjusted analyses, 3 SNPs within the top 120 by P value in the lo- gistic analysis and 1 in the Cox analysis of the Canadian data set provided additional evidence for association at P?.05 within the United Kingdom Medical Research Council data set: RS7019241 (GOLPH2), RS10868366 (GOLPH2), RS9886784 (chromosome 9), and RS10519262 (intergenic between ATP8B4 and SLC27A2). Conclusions:Ourgenomewide association analysis again identified the APOE linkage disequilibrium region as the strongest genetic risk factor for AD. This could be a con- sequence of the coevolution of more than 1 susceptibil- ity allele, such as APOC1, in this region. We also pro- vide new evidence for additional candidate genetic risk factors

Cite

CITATION STYLE

APA

Hosford, D., Barnes, M. R., Briley, J. D., Borrie, M., Coletta, N., Delisle, R., … Johnson, J. (2008). Candidate Single-Nucleotide Polymorphisms From a Genomewide Association Study of Alzheimer Disease. Archives of Neurology, 65(1), 45–53.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free